Alcidion Group Limited · ASX:ALC
Alcidion — Investor Presentation (May 2016)
17 slides from Alcidion's investor presentation, Apr 29, 2016
Slide 1: Wholesale Investor Presentation
For personal use only Alcidion Group Limited Wholesale Investor Presentation May 2016 1
Slide 2: Disclaimer
DISCLAIMER Disclaimer For personal use only This presentation has been prepared by Alcidion Group Limited (the "Company"). It does not purport to contain all the information that a prospective investor may require in connection with any potential investment in the Company. You should not treat the c
Slide 3: Introduction
For personal use only INTRODUCTION Nathan Buzza Executive Director Alcidion Corporation nathan.buzza@alcidion.com Mobile +61 4 8886 2222 www.alcidion.com 3
Slide 4: Executive Summary
For personal use only Executive Summary 4
Slide 5: Corporate snapshot
ASX Ticker ALC Market Capitalisation $30m For personal use only 40% Founders 15% BlueSky Private Equity Ownership 9% Owned by Employees 6% Allure Capital Share Price 5.00c Cash on hand $6.00m Enterprise Value $24m Shares on Issue 603m FY15 Revenues $5.05m, Audited FY15 EBITDA $183k Loss, Audited Emp
Slide 6: Board of Directors
For personal use only BOARD OF DIRECTORS Chief Medical Officer Chief Executive Officer Executive Director Non-Executive Director Prof. Malcolm Pradhan Mr. Ray Blight Mr. Nathan Buzza Mr. Nick Dignam • Formal qualifications in • Formal qualifications include a • Former CEO of Clinical • Formal qualif
Slide 7: Executive Summary
For personal use only EXECUTIVE SUMMARY ● Hospitals are built upon a complex eco-system of disparate Clinical Information Systems (CIS). ● Alcidion’s Miya platform integrates disparate Clinical Information Systems to identify emerging clinical risk and push this clinical intelligence to the care tea
Slide 8: Global State of the Market
For personal use only GLOBAL STATE OF THE MARKET ● Global expenditure on Healthcare IT is $USD40.4b, growing to $USD56.7b by 2017. ● Mobile Health technology is growing from $USD6.9b market in 2014 to $USD23b market by 2017. ● The Clinical Decision Support Systems Market is set to grow 21.5% CAGR fr
Slide 9: BlueSky investor quote
For personal use only “At BlueSky we meticulously evaluate every opportunity. Alcidion ticked all the boxes: Mobile, Healthcare, Information Technology, coupled with an internationally recognized Management Team.” Nick Dignam Investment Director Blue Sky Private Equity 10
Slide 10: Allure Capital investor quote
“What really struck me about Alcidion For personal use only was the deep seated passion of the founders to fix healthcare – coupled with their impeccable qualifications” Nathan Buzza Allure Capital 11
Slide 11: South Australia Premier quote on Miya
“...the Miya platform is For personal use only creating a great deal of interest. It’s being used in hospitals across Australia and New Zealand, and there’s a possibility it will be trialed here in South Australia soon.” Jay Weatherill MP Premier of South Australia 12
Slide 12: Unique Opportunity To Be Part of the New Digital Health Economy
Unique Opportunity To Be Part of the New Digital Health Economy For personal use only The introduction of the Patient Protection & Affordable Care Act 2010 (“Obamacare”) requires US hospitals to adopt Electronic Medical Records or face a reduction in Medicare reimbursements. 13
Slide 13: Experienced Management Team
Experienced Management Team For personal use only “Capable and Experienced Management Team with a strong track record of commercializing healthcare software, including the former CEO & Chairman of the South Australian Health Commission, a Stanford qualified Medical Doctor and a former Ernst & Young
Slide 14: Proven Technology
Proven Technology For personal use only Alcidion’s platform is installed into 11 large tertiary hospitals including Footscray, Sunshine, Williamstown, Royal Darwin & Alice Springs Hospitals and throughout Tasmania. 15
Slide 15: Disruptive Technology Platform
Disruptive Technology Platform For personal use only The platform is at the forefront of medical technology, on the crest of the next generation of healthcare technologies. 16
Slide 16: Strong Growth Platform
Strong Growth Platform For personal use only The business recently secured a $1.75m contract with the Northern Territory Health Department to roll out a pilot of the Computerised Physician Order Entry technology (CPOE). Several new contracts are presently being negotiated with leading public and pri
Slide 17: Fully Funded
Fully Funded For personal use only The recent listing of Alcidion on the ASX will see the company fully funded, with $6.00m in cash and debt free. 18